2025 Hyper Recent •CC0 1.0 Universal

This work is dedicated to the public domain. No rights reserved.

Access Preprint From Server
July 3rd, 2025
Version: 2
University of Dundee
cancer biology
biorxiv

Cell enlargement causes mitotic errors and aneuploidy in cells that evade senescence after CDK4/6 inhibition

Pareri, A. U.Open in Google Scholar•Losito, M.Open in Google Scholar•Foijer, F.Open in Google Scholar•Saurin, A. T.Open in Google Scholar

CDK4/6 inhibitors (CDK4/6i) arrest the cell cycle in G1 leading to cellular overgrowth and p53-dependent senescence. They are used to treat metastatic HR+/HER2- breast cancer, but resistance is common, and this has been associated with TP53 loss and senescence evasion. We show here that enlarged CDK4/6i-treated cells that evade senescence mis-segregate chromosomes due to defective chromosomal alignment and a weakened mitotic checkpoint, leading to aneuploidy and DNA damage. The chromosome alignment errors are associated with impaired Sgo1 localisation to centromeres and defective sister chromatin cohesion during mitosis. Importantly, all these mitotic defects can be rescued by constraining cell size during the CDK4/6i-treatment, and specifically restoring cohesion rescues the chromosome segregation errors. Together, this demonstrates mechanistically how cell enlargement drives genetic and karyotypic change in cells that re-enter the cell cycle following CDK4/6 inhibition. This could help fuel the rapid emergence of chemotherapy-resistant clones, especially in p53-null cells that evade senescence to drive drug-resistance in patients.

Similar Papers

biorxiv
Thu Jul 03 2025
Cell Settling, Migration, and Stochastic Cancer Expression Suggest Potassium Flux Per H+- Sensitive KCN Members Associated with Oncogenes and Histone/DNA Modulators Potentially Initiates pH-Reversal
Attraction of glioblastoma cells to potassium was suspected when cells clustered around dying cells and they migrated towards serum (high [K+]) and a positive potassium gradient. Potassium channel proteins (KCN family, 90 members) mediating altered transmembrane flux may provide K+ that releases H+ bound to inner membranes in cancer cells for cytosolic proton transfer (possibly Grotthuss) to extru...
Beckner, M.
biorxiv
Thu Jul 03 2025
Bedaquiline Amplifies Proteasome Inhibitor Efficacy and Overcomes Resistance in Multiple Myeloma
Proteasome inhibitors (PIs) are cornerstone therapies for multiple myeloma (MM), yet resistance remains a major barrier to durable responses. To identify druggable vulnerabilities that enhance PI efficacy, we performed a small-molecule chemical screen in the presence of carfilzomib (CFZ). We identified bedaquiline (BDQ), an FDA-approved antimycobacterial agent, as a potent synergistic partner. BDQ...
Cumerlato, M.
•
Maccagno, M.
•
Labrador, M.
•
Luciano, B.
...•
PIVA, R.
biorxiv
Thu Jul 03 2025
Multi-gradient Permutation Survival Analysis Identifies Mitosis and Immune Signatures Steadily Associated with Cancer Patient Prognosis
The inconsistency of the association between genes and cancer prognosis is often attributed to many variables that contribute to patient survival. Whether there exist the Genes Steadily Associated with Prognosis (GEARs) and what their functions are remain largely elusive. Here we developed a novel method named "Multi-gradient Permutation Survival Analysis " (MEMORY) to screen the GEARs by using RN...
Cai, X.
•
Ye, Y.
•
Liu, X.
•
Fang, Z.
...•
Ji, H.
biorxiv
Thu Jul 03 2025
Intrinsic higher potency of basal urothelial cells to intermediate and umbrella cells as the cell of origin for bladder cancer
Transcriptome profiling of bladder cancer has revealed distinct basal-like and luminal-like molecular subtypes, which may be correlated with pathological subtypes of different patient outcomes. However, whether these molecular subtypes originate from the corresponding cell types in the normal urothelium and whether different cells of origin influence bladder cancer progression remain unclear. Here...
Yu, C.
•
Chu, N.
•
Aguirre, A.
•
Green, J.
...•
Wang, Z. A.
biorxiv
Thu Jul 03 2025
CIT tumor lines: A novel series of immunogenic cutaneous squamous cell carcinoma cell lines derived from chemical carcinogenesis
Immunotherapy is now widely used to treat advanced-stage skin cancer, but it is effective for only approximately half of skin cancer patients, including both patients with melanoma and cutaneous squamous cell carcinoma (cSCC). To overcome current barriers, preclinical mouse models that faithfully recapitulate the tumor genetics, mutation burdens, and neoantigen patterns of specific human tumor typ...
Letchworth, R.
•
Tanaka, M.
•
Barnes, A. A.
•
Lum, L.
...•
Reeves, M.
biorxiv
Thu Jul 03 2025
Interplay of YEATS2 and GCDH regulates histone crotonylation and drives EMT in head and neck cancer
The regulation of gene expression is an integral cellular process orchestrated by epigenetic marks like histone modifications. Perturbations in the activity or abundance of epigenetic factors can lead to tumorigenesis. Remarkably, several metabolites influence the epigenetic landscape in cells. Here, we investigated the interplay between a highly expressed epigenetic factor, YEATS2, and a metaboli...
Pant, D.
•
KAKANI, P.
•
Joshi, R.
•
Sabu, A.
...•
Shukla, S.
biorxiv
Wed Jul 02 2025
KLF5 controls subtype-independent highly interactive enhancers in pancreatic cancer to regulate cell survival
Pancreatic ductal adenocarcinoma (PDAC) remains a highly lethal cancer with a 5-year survival rate of 13%. Despite recent molecular stratification of tumors into distinct classical and basal-like cell states, most tumors are heterogeneous contain of both subtypes. Therefore, therapeutic approaches targeting one subtype may not be suitable for PDAC therapy. Here, we integrated chromatin accessibili...
Ekstrom, T. L.
•
Saha, B. J.
•
Thiel, J.
•
Dai, Z.
...•
Johnsen, S. A.
biorxiv
Wed Jul 02 2025
KAT6A/B inhibition synergizes with retinoic acid and enhances the efficacy of GD2-targeted immunotherapy in neuroblastoma
High-risk neuroblastoma accounts for about 15% of childhood cancer deaths and arises from precursors of the peripheral sympathetic nervous system. Retinoids are clinically used to inhibit growth of neuroblastoma cells through reconfiguration of the regulatory enhancer landscape. Its effects, however, are completely reversible after drug withdrawal, leading to rapid tumor cell proliferation. Here, ...
Weichert-Leahey, N.
•
Berezovskaya, A.
•
Zimmerman, M. W.
•
Alvarez-Caldero, F.
...•
Look, A. T.
biorxiv
Wed Jul 02 2025
Exosomal cargo genes as biomarkers and potential mediators of exosome-driven cell communication in Pleural Mesothelioma
Pleural mesothelioma (PM) is a rare yet aggressive and heterogeneous cancer type with very poor survival rates. Due to its long latency period and nonspecific symptoms, the disease is usually detected at advanced stages, limiting available treatment options and leading to poor survival rates. So far, the disease can only be confirmed through invasive thoracoscopic biopsy. Moreover, the proposed ci...
Kraft, A.
•
Toenz, A.
•
Schlaepfer, F.
•
Ronner, M.
...•
Meerang, M.